XML 67 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity - Additional Information (Detail) - USD ($)
12 Months Ended
Apr. 14, 2017
Jan. 15, 2017
Jan. 13, 2017
Oct. 14, 2016
Jul. 15, 2016
Apr. 15, 2016
Oct. 16, 2015
Jul. 17, 2015
Apr. 17, 2015
Feb. 27, 2015
Feb. 03, 2018
Jan. 28, 2017
Jan. 30, 2016
Schedule of Shareholders' Equity [Line Items]                          
Dividends declared and cash paid per share $ 0.075 $ 0.075 $ 0.075 $ 0.075 $ 0.075 $ 0.075 $ 0.075 $ 0.075 $ 0.075 $ 5.000 $ 0.075 $ 0.30 $ 5.30
Repurchase of shares                     81,232 224,344 262,219
Repurchase shares value                     $ 200,000 $ 1,700,000 $ 3,600,000
Expected volatility                     43.10% 40.30% 38.50%
Dividend yield                     8.10% 4.00% 3.10%
Risk-free interest rate                     1.90% 1.60% 1.30%
Expected option term                     5 years 5 years 7 months 6 days 4 years 10 months 25 days
Share-based compensation expense                     $ 5,691,000 $ 7,923,000 $ 6,516,000
Weighted-average grant-date fair value of options granted                     $ 0.82 $ 2.36 $ 2.50
Income tax benefit                     $ 11,698,000 $ 719,000 $ (14,569,000)
Number of options, exercised                     0    
2001 Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Number of shares authorized under plan                     12,500,000    
2018 Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Number of shares authorized under plan                     4,100,000    
Stock Options [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Stock option exercisable terms and conditions                     One-third of the awards vest on each of the third, fourth and fifth-anniversary dates of grant. Awards under the 2001 Plan granted subsequent to 2013 generally vest monthly in equal amounts over a five-year period. The awards expire seven to ten years after the date of grant.    
Closing stock price per share                     $ 0.65    
Money option outstanding                     $ 0    
Aggregate intrinsic value of outstanding and exercisable stock options                     0    
Unrecognized compensation cost                     $ 1,500,000    
Shares, Weighted-average expected life remaining                     1 year 3 months 19 days    
Total intrinsic value of stock options exercised                       600,000 900,000
Income tax benefit                       200,000 200,000
Number of options, exercised                     0    
Incremental share based compensation                     $ 0    
Stock Options [Member] | 2001 Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Award vesting period                     5 years    
Stock Options [Member] | Minimum [Member] | 2001 Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Expiration period of options                     7 years    
Stock Options [Member] | Minimum [Member] | 2018 Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Award vesting period                     1 year    
Stock Options [Member] | Maximum [Member] | 2001 Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Expiration period of options                     10 years    
Restricted Stock Awards [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Total fair value, vested                     $ 1,000,000 3,300,000 3,000,000
Restricted Stock Awards [Member] | Maximum [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Shares, Weighted-average expected life remaining                     1 year 1 month 6 days    
Performance Share Awards [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Total fair value, vested                     $ 0 $ 1,600,000 $ 4,800,000
Performance Share Awards [Member] | Minimum [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Shares, Weighted-average expected life remaining                     7 months 28 days    
Restricted Stock and Performance Share Awards [Member] | Minimum [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Award vesting period                     3 years    
Restricted Stock and Performance Share Awards [Member] | Maximum [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Award vesting period                     5 years    
Employee Stock Purchase Plan [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Completion period for ESOP participation eligibility                     6 months    
Regular scheduled period for ESOP participation eligibility                     20 hours    
Discount for participants under stock purchase plan                     85.00%    
Number of shares authorized under plan                     2,900,000    
Number of shares available each year                     200,000    
Shares acquired by participants                     228,562 145,136 111,806
Weighted average price per share                     $ 1.44 $ 5.13 $ 6.87
Expected volatility                     61.40%    
Dividend yield                     5.47%    
Risk-free interest rate                     0.62%    
Present value discount factor                     1.00%    
Expected option term                     6 months    
Share-based compensation expense                     $ 300,000 $ 300,000 $ 300,000
Shares authorized under the Stock Purchase Plan                     15,452    
Board of Directors [Member]                          
Schedule of Shareholders' Equity [Line Items]                          
Repurchase of shares, remaining                     415,298